“For many cell-based therapies, progress comes from connecting the right pieces at the right moment,” Klein said. “When biology, computation, and the right support come together, you can start to move ...

BrainChild Bio advancing BCB-276 towards BLA submission with a single pivotal Phase 2 trial planned to commence in Q4 2025 SEATTLE & CAMBRIDGE, Mass.--(BUSINESS WIRE)--BrainChild Bio, Inc., a clinical ...

At WCLC, Nuvation Bio will also sponsor a satellite symposium, titled “Under the Microscope: Focusing on ROS1+ NSCLC,” on Sunday, September 7 from 1:45 – 2:45 p.m. CEST. Presenters include Charu ...

Stem cells hold immense potential in research and therapeutic development. One area where they are being utilized is in the development of advanced cell models, such as organoids. Stem cell-derived ...

Boosted CAR: A2B543 is enhanced with a membrane-tethered IL-12 booster to augment therapeutic potency Robustness: Tmod™ platform continues to demonstrate selectivity against cancer and adaptability to ...

– New collaboration builds on Sanofi’s prior acquisition of DR-0201 and further leverages Dren Bio’s proprietary Targeted Myeloid Engager and Phagocytosis Platform to discover first-in-class ...

About Advanced Biomed Inc. Advanced Biomed Inc. is a Nevada corporation specializing in innovative biomedical technologies for cancer detection and precision medicine.

Bio X Cell, the global leader of functional antibodies for in vivo and emerging preclinical models, unveils a refreshed brand identity which bridges nearly 30 years of scientific leadership in the ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, has announced a Technology Alliance Agreement with the Chan Zuckerberg Institute for Advanced ...